Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
12L polyethylene glycol/ascorbic acid[2] Ascorbic acid,
Polyethylene glycol		[2] D00018 ,
D03370 (Name: Polyethylene glycol 3350)		--[1] 97
2C-TYPE NATRIURETIC PEPTIDE CONJUGATED TO MULTI-ARM POLYETHYLENE GLYCOL CARRIER THROUGH A CLEAVABLE LINKER[1] Polyethylene glycol[1] D03370 (Name: Polyethylene glycol 3350)--[1] 276
3Polyethylene glycol[1] Polyethylene glycol[1] D03370 (Name: Polyethylene glycol 3350)--[7] 6, 78, 96, 97, 235, 276, 299
4Polyethylene Glycol 3350[1] Polyethylene glycol[1] D03370 (Name: Polyethylene glycol 3350)--[2] 96, 299
5Sodium phosphate enema, oral rifaximin and polyethylene glycol[3] Phosphate ion,
Polyethylene glycol,
Rifaximin		[2] D02554 ,
D03370 (Name: Polyethylene glycol 3350)		--[1] 6
6Teriparatide conjugated to a multiarm polyethylene glycol carrier molecule through a cleava[2] Polyethylene glycol,
Teriparatide		[2] D03370 (Name: Polyethylene glycol 3350),
D06078 		[1] PTH1R 💬[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 235
7Teriparatide conjugated to a multiarm polyethylene glycol carrier molecule through a cleavable linker[2] Polyethylene glycol,
Teriparatide		[2] D03370 (Name: Polyethylene glycol 3350),
D06078 		[1] PTH1R 💬[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 235
8Treatment with polyethylene glycol (Macrogol 4000)[1] Polyethylene glycol[1] D03370 (Name: Polyethylene glycol 3350)--[1] 299